Back to KROS

Invesco Ltd. → KROS

Invesco Ltd. KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
12
Latest value
$715K
Q3 2026
Peak value
$1.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$445K
Q4 2025$95K
Q4 2025$1.2M
Q1 2026$241K
Q1 2026$44K
Q1 2026$684K
Q2 2026$81K
Q2 2026$24K
Q2 2026$661K
Q3 2026$79K
Q3 2026$24K
Q3 2026$715K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$715K62.7K——
Q3 2026$24K2.1K——
Q3 2026$79K6.9K——
Q2 2026$661K61.7K——
Q2 2026$24K2.2K——
Q2 2026$81K7.6K——
Q1 2026$684K61.9K——
Q1 2026$44K4.0K——
Q1 2026$241K21.9K——
Q4 2025$1.2M60.9K——
Q4 2025$95K4.7K——
Q4 2025$445K21.9K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other Invesco Ltd. positions

NVDA

NVIDIA CORPORATION

$55.5B
AAPL

APPLE INC

$52.6B
NVDA

NVIDIA CORPORATION

$52.6B
AAPL

APPLE INC

$45.9B
MU

MICRON TECHNOLOGY INC

$39.4B
MSFT

MICROSOFT CORP

$38.6B
NVDA

NVIDIA CORP NVDA

$36.9B
MU

MICRON TECHNOLOGY INC

$34.9B